BR100 Increased By (0.4%)
BR30 Increased By (0.6%)
KSE100 Increased By (0.29%)
KSE30 Increased By (0.26%)
BECO 6.12 Increased By ▲ 0.35 (6.07%)
BML 52.70 Decreased By ▼ -0.30 (-0.57%)
BOP 34.27 Increased By ▲ 0.28 (0.82%)
CNERGY 8.15 Increased By ▲ 0.04 (0.49%)
DCL 12.06 Decreased By ▼ -0.14 (-1.15%)
FCCL 53.30 Increased By ▲ 0.47 (0.89%)
FCSC 5.16 Increased By ▲ 0.09 (1.78%)
FFL 18.01 Increased By ▲ 0.06 (0.33%)
FNEL 1.31 Increased By ▲ 0.02 (1.55%)
HUMNL 10.88 No Change ▼ 0.00 (0%)
KEL 8.14 Increased By ▲ 0.12 (1.5%)
KOSM 5.36 Decreased By ▼ -0.16 (-2.9%)
MLCF 87.00 Increased By ▲ 0.49 (0.57%)
NBP 186.50 Increased By ▲ 1.34 (0.72%)
PACE 10.69 Increased By ▲ 0.11 (1.04%)
PAEL 39.79 Increased By ▲ 0.37 (0.94%)
PIAHCLA 26.17 Decreased By ▼ -0.05 (-0.19%)
PIBTL 16.92 Increased By ▲ 0.25 (1.5%)
PPL 228.78 Increased By ▲ 0.60 (0.26%)
PRL 34.85 Increased By ▲ 0.17 (0.49%)
PTC 66.75 Increased By ▲ 1.42 (2.17%)
SEARL 90.68 Increased By ▲ 0.55 (0.61%)
SSGC 27.00 Increased By ▲ 0.40 (1.5%)
TELE 8.62 Increased By ▲ 0.34 (4.11%)
THCCL 58.30 Decreased By ▼ -0.20 (-0.34%)
TPLP 8.63 Increased By ▲ 0.41 (4.99%)
TREET 24.60 Increased By ▲ 0.07 (0.29%)
TRG 69.51 Decreased By ▼ -0.20 (-0.29%)
WAVES 9.91 Decreased By ▼ -0.03 (-0.3%)
WTL 1.29 Increased By ▲ 0.01 (0.78%)
Topic

Bayer

Bayer's agriculture business buoyed by higher produce prices in Q1

Bayer's agriculture business buoyed by higher produce prices in Q1

Published 23 Apr, 2021 06:03pm
  • In the agriculture business, in particular, we see a market environment that gives us an increasingly positive perspective.
  • "A sizable increase in the demand for agricultural products has led to rising prices. Of course, we hope that this momentum will continue."
Bayer aims to deliver first doses of CureVac's COVID-19 shot in Q4

Bayer aims to deliver first doses of CureVac's COVID-19 shot in Q4

Published 15 Feb, 2021 05:20pm
  • We are very confident that we will even be able to deliver the first vaccines before the end of the year, if all goes well.
  • German biotech company CureVac, which began late-stage testing of the vaccine in December and expects to announce interim results this quarter
Loading...